Boehringer's Mirapex Patent Declared Invalid
By Amanda Ernst · June 27, 2008, 12:00 AM EDT
In a blow to German pharmaceutical company Boehringer Ingelheim International GmbH, a federal judge has ruled that a patent covering the company's restless leg syndrome treatment Mirapex is invalid due to...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login